| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/2010 | US20100234470 Instillation Administration of Capsaicinoids for the Treatment of Pain |
| 09/16/2010 | US20100234469 New Crystals Of A Benzoylbenzeneacetamide Derivative |
| 09/16/2010 | US20100234468 Novel process |
| 09/16/2010 | US20100234467 Methods for improving bioavailability of a renin inhibitor |
| 09/16/2010 | US20100234466 Compositions and Methods for Reducing Body Fat |
| 09/16/2010 | US20100234465 Administration of Intravenous Ibuprofen |
| 09/16/2010 | US20100234464 Compounds for the treatment of metabolic disorders |
| 09/16/2010 | US20100234463 Method for Identifying Modulators of Gamma Secretase or Notch |
| 09/16/2010 | US20100234462 Topical composition |
| 09/16/2010 | US20100234461 Compositions For Improved Oxidative Status In Companion |
| 09/16/2010 | US20100234460 Compositions Comprising A C2-C14 Carboxylic Acid And A Surfactant For Treating Hoof Diseases |
| 09/16/2010 | US20100234459 Medicall use of 3-(2,2,2,-trimethylyhdrazinium) propionate hdrogen fumarate and dihydrogen phosephate |
| 09/16/2010 | US20100234456 Apoptosis promoters |
| 09/16/2010 | US20100234455 Histone Deacetylase Inhibitors |
| 09/16/2010 | US20100234454 Treatment of cnidaria intoxication |
| 09/16/2010 | US20100234453 Pharmaceutical composition containing phenanthrenequinone-based compound for intestine delivery system |
| 09/16/2010 | US20100234452 Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders |
| 09/16/2010 | US20100234451 Lna antagonists targeting the androgen receptor |
| 09/16/2010 | US20100234450 Molecular targeting agents |
| 09/16/2010 | US20100234449 Immunostimulatory Method |
| 09/16/2010 | US20100234448 In vivo production of small interfering rnas that mediate gene silencing |
| 09/16/2010 | US20100234447 Modulation of glucagon receptor expression |
| 09/16/2010 | US20100234446 RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof |
| 09/16/2010 | US20100234445 Patterns of known and novel small RNAS in human cervical cancer |
| 09/16/2010 | US20100234444 Hindered ester-based biodegradable linkers for oligonucleotide delivery |
| 09/16/2010 | US20100234443 Combinations of statins and anti-obesity agent |
| 09/16/2010 | US20100234442 Compositions and Methods for Treatment and Prevention of Cardiovascular Disease |
| 09/16/2010 | US20100234441 Novel compounds |
| 09/16/2010 | US20100234440 Novel crystal of substituted phenylalkanoic acid ester and process for producing the same |
| 09/16/2010 | US20100234439 Therapeutic agents |
| 09/16/2010 | US20100234438 Therapeutic agents |
| 09/16/2010 | US20100234435 Cycloalkylamino acid derivatives |
| 09/16/2010 | US20100234434 Flavivirus inhibition by sultams and related compounds |
| 09/16/2010 | US20100234433 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
| 09/16/2010 | US20100234432 Substituted 6-phenylnicotinic acids and their use |
| 09/16/2010 | US20100234431 Pyrrolidine compounds |
| 09/16/2010 | US20100234430 Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments |
| 09/16/2010 | US20100234429 Substituted nicotinamides as kcnq2/3 modulators |
| 09/16/2010 | US20100234428 Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators |
| 09/16/2010 | US20100234427 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 09/16/2010 | US20100234426 Phenylpropionamide Compounds and the Use Thereof |
| 09/16/2010 | US20100234425 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors |
| 09/16/2010 | US20100234424 Derivatives of n-phenyl(piperidine-2-yl) methyl benzamide preparation method thereof and applications of same in therapeutics |
| 09/16/2010 | US20100234423 Triazolothiadiazole inhibitor of c-met protein kinase |
| 09/16/2010 | US20100234422 Sulfonylated Heterocycles Useful for Modulation of the Progesterone Receptor |
| 09/16/2010 | US20100234421 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators |
| 09/16/2010 | US20100234420 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders |
| 09/16/2010 | US20100234419 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators |
| 09/16/2010 | US20100234418 Compounds and uses thereof |
| 09/16/2010 | US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 09/16/2010 | US20100234416 Use of huperzine for disorders |
| 09/16/2010 | US20100234415 Indole derivatives as crth2 receptor antagonists |
| 09/16/2010 | US20100234414 Use of Loratadine 10mg for the prevention of upper respiratory inflammation/sinus infections caused from exposure to bacteria and viruses on airplane flights |
| 09/16/2010 | US20100234413 Compositions and methods for prophylaxis and treatment of addictions |
| 09/16/2010 | US20100234412 Buprenorphine Derivatives and Uses Thereof |
| 09/16/2010 | US20100234411 New Combination for the Treatment of Respiratory Diseases |
| 09/16/2010 | US20100234410 Hydrate for medical purposes |
| 09/16/2010 | US20100234409 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 09/16/2010 | US20100234408 Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis |
| 09/16/2010 | US20100234407 Preventives/remedies for myeloma tumor and method for diagnosing the same |
| 09/16/2010 | US20100234406 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 09/16/2010 | US20100234405 Pyrimidine nucleoside derivatives and salts thereof |
| 09/16/2010 | US20100234404 P-38 Kinase Inhibitors |
| 09/16/2010 | US20100234403 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 09/16/2010 | US20100234402 Methods and compositions for treating spinal muscular atrophy |
| 09/16/2010 | US20100234401 6,9-Disubstituted Purine Derivatives and Their Use For Treating Skin |
| 09/16/2010 | US20100234400 Compounds that maintain pluripotency of embryonic stem cells |
| 09/16/2010 | US20100234399 Agent for overcoming resistance to anti-cancer agent |
| 09/16/2010 | US20100234397 Enzyme inhibitors |
| 09/16/2010 | US20100234396 Tetrhydropyridoindole Derivatives |
| 09/16/2010 | US20100234395 Ureide derivative and pharmaceutical application thereof |
| 09/16/2010 | US20100234394 Substituted benzimidazoles and methods of their use |
| 09/16/2010 | US20100234393 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension |
| 09/16/2010 | US20100234392 4-sulfonylpiperidine derivatives |
| 09/16/2010 | US20100234390 Novel compound and their use |
| 09/16/2010 | US20100234389 Amide compound |
| 09/16/2010 | US20100234388 Substituted pde5 inhibitors |
| 09/16/2010 | US20100234387 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals |
| 09/16/2010 | US20100234386 Quinoxaline derivatives as pi3 kinase inhibitors |
| 09/16/2010 | US20100234385 Compsition Containing Biopterin and Method for Using The Same |
| 09/16/2010 | US20100234384 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists |
| 09/16/2010 | US20100234383 Treating, preventing or ameliorating a hyperproliferative disease/disorder |
| 09/16/2010 | US20100234382 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 09/16/2010 | US20100234381 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 09/16/2010 | US20100234380 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor |
| 09/16/2010 | US20100234379 Dual modulation of endocannabinoid transport and fatty-acid amide hydrolase for treatment of excitotoxicity |
| 09/16/2010 | US20100234378 Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors |
| 09/16/2010 | US20100234377 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 09/16/2010 | US20100234376 [4,5']Bipyrimidinyl-6,4'-Diamine Deriviatives as Protein Kinase Inhibitors |
| 09/16/2010 | US20100234375 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 09/16/2010 | US20100234374 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 09/16/2010 | US20100234373 Bis-aryl amide compounds and methods of use |
| 09/16/2010 | US20100234372 Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators |
| 09/16/2010 | US20100234371 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof |
| 09/16/2010 | US20100234370 Pharmaceutical compounds |
| 09/16/2010 | US20100234369 5-cyanothienopyridines for the treatment of tumours |
| 09/16/2010 | US20100234368 Condensed ring compound and use thereof |
| 09/16/2010 | US20100234367 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| 09/16/2010 | US20100234366 Use of Strobilurins for the Treatment of Disorders of Iron Metabolism |
| 09/16/2010 | US20100234365 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |